ML-191 structure
|
Common Name | ML-191 | ||
---|---|---|---|---|
CAS Number | 931695-79-3 | Molecular Weight | 403.474 | |
Density | 1.3±0.1 g/cm3 | Boiling Point | 569.5±60.0 °C at 760 mmHg | |
Molecular Formula | C24H25N3O3 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 298.2±32.9 °C |
Use of ML-191ML-191 is an antagonist of GPR55. It inhibits GPR55 signaling induced by lysophosphatidylinositol (EC50=1.076 µM in U2OS cells overexpressing GPR55). ML-191 inhibits LPI-induced phosphorylation of ERK1/2 (IC50=328 nM) and receptor-dependent translocation of PKCβII when used at a concentration of 30 µM[1]. |
Name | 3-(1-{[1-(4-Methylphenyl)cyclopropyl]carbonyl}-4-piperidinyl)-5-p henyl-1,3,4-oxadiazol-2(3H)-one |
---|---|
Synonym | More Synonyms |
Description | ML-191 is an antagonist of GPR55. It inhibits GPR55 signaling induced by lysophosphatidylinositol (EC50=1.076 µM in U2OS cells overexpressing GPR55). ML-191 inhibits LPI-induced phosphorylation of ERK1/2 (IC50=328 nM) and receptor-dependent translocation of PKCβII when used at a concentration of 30 µM[1]. |
---|---|
Related Catalog | |
References |
[1]. Heynen-Genel S, et al. Screening for Selective Ligands for GPR55 - Antagonists. 2010 Oct 30 |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 569.5±60.0 °C at 760 mmHg |
Molecular Formula | C24H25N3O3 |
Molecular Weight | 403.474 |
Flash Point | 298.2±32.9 °C |
Exact Mass | 403.189606 |
PSA | 68.34000 |
LogP | 2.75 |
Vapour Pressure | 0.0±1.6 mmHg at 25°C |
Index of Refraction | 1.668 |
3-(1-{[1-(4-Methylphenyl)cyclopropyl]carbonyl}-4-piperidinyl)-5-phenyl-1,3,4-oxadiazol-2(3H)-one |
1,3,4-Oxadiazol-2(3H)-one, 3-[1-[[1-(4-methylphenyl)cyclopropyl]carbonyl]-4-piperidinyl]-5-phenyl- |